Worthington Enterprises
WOR
60.45
-1.19
-1.93%
Worthington Enterprises
US · WOR
#2494 by market cap
Listed 1970
60.45
-1.19
-1.93%
Live - 5344 symbols - heartbeat 127s ago
· 2026-10-08 08:08
Pre-market
61.00
+0.91%
After-hours
60.45
0.00%
- Market cap
- 2.96B
- P/E (TTM)i
- 18.26
- P/Bi
- 2.82
- EPSi
- 3.14
- Div yieldi
- 1.26%
- 52W posi
- 69%
Reader sentiment
Are you bullish or bearish on WOR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.79, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +19.72% YoY
Margins
- Gross margin
- 27.39%
- Operating margin
- 6.03%
- Net margin
- 11.30%
Key ratios & quality
- Enterprise valuei
- 3.24B
- Altman Z-Scorei
- 3.79
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.76B | 3.06B | 3.17B | 1.31B | 1.42B | 1.25B | 1.15B | 1.38B |
| Gross profit | 479.96M | 443.34M | 639.08M | 327.61M | 323.59M | 285.02M | 319.04M | 378.28M |
| Selling & admin expenses | 338.39M | 328.11M | 351.15M | 281.43M | 287.12M | 283.47M | 268.41M | 294.97M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 141.56M | 115.23M | 287.93M | 46.18M | 36.47M | 1.55M | 50.62M | 83.31M |
| Pretax profit | 206.46M | 110.79M | 917.72M | 210.65M | 160.29M | 74.01M | 128.81M | 201.35M |
| Tax | 43.18M | 26.34M | 176.27M | 52.70M | 34.54M | 39.03M | 33.84M | 46.31M |
| Net profit | 163.27M | 84.44M | 741.45M | 399.26M | 269.17M | 117.82M | 94.97M | 155.04M |
| Basic EPS | 3 | 1 | 14 | 8 | 5 | 2 | 2 | 3 |
| Diluted EPS | 2.61 | 1.41 | 13.42 | 7.44 | 5.19 | 2.20 | 1.92 | 3.14 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 317.88M | 303.71M | 327.45M | 378.68M | 371.46M | 343.89M |
| Gross profit | 93.23M | 82.28M | 84.63M | 109.47M | 101.89M | 90.90M |
| Selling & admin expenses | 71.45M | 70.57M | 70.72M | 75.75M | 77.94M | 77.16M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 21.78M | 11.72M | 13.91M | 33.73M | 23.95M | 13.74M |
| Pretax profit | 8.33M | 45.68M | 35.78M | 60.11M | 59.77M | 55.60M |
| Tax | 4.72M | 10.86M | 8.75M | 14.99M | 11.71M | 13.03M |
| Net profit | 3.61M | 34.82M | 27.03M | 45.12M | 48.07M | 42.57M |
| Basic EPS | 0 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.08 | 0.70 | 0.55 | 0.92 | 0.97 | 0.87 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.17B | 983.18M | 1.97B | 1.79B | 1.87B | 673.89M | 685.37M | 524.47M |
| Cash & ST investments | 92.36M | 147.20M | 640.31M | 34.49M | 422.27M | 244.23M | 250.08M | 27.73M |
| Inventory | 484.28M | 405.10M | 564.75M | 759.14M | 194.50M | 164.62M | 169.39M | 207.30M |
| Total assets | 2.51B | 2.33B | 3.37B | 3.64B | 3.65B | 1.64B | 1.70B | 1.85B |
| Total current liabilities | 698.02M | 388.24M | 787.90M | 932.26M | 717.56M | 178.38M | 196.84M | 221.43M |
| Short-term debt | 150.94M | 11.00M | 10.41M | 59.88M | 6.95M | 6.23M | 6.01M | 7.98M |
| Long-term debt | 598.36M | 699.52M | 710.03M | 696.35M | 689.72M | 298.13M | 302.87M | 305.90M |
| Total liabilities | 1,562,402,000.00 | 1,365,082,000.00 | 1,821,550,000.00 | 2,029,061,000.00 | 1,829,290,000.00 | 747,625,000.00 | 756,915,000.00 | 821,024,000.00 |
| Total equity | 948.39M | 966.43M | 1.55B | 1.61B | 1.82B | 891.01M | 938.24M | 1.03B |
| Retained earnings | 591.53M | 572.26M | 1.07B | 1.23B | 1.43B | 589.39M | 624.53M | 704.14M |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 685.37M | 626.04M | 648.78M | 503.86M | 524.47M | 522.71M |
| Cash & ST investments | 250.08M | 167.12M | 180.29M | 5.98M | 27.73M | 55.07M |
| Inventory | 169.39M | 201.56M | 198.44M | 197.59M | 207.30M | 222.59M |
| Total assets | 1.70B | 1.74B | 1.75B | 1.82B | 1.85B | 1.84B |
| Total current liabilities | 196.84M | 189.79M | 199.07M | 213.24M | 221.43M | 196.05M |
| Short-term debt | 6.01M | 7.56M | 8.47M | 12.74M | 7.98M | 7.97M |
| Long-term debt | 302.87M | 306.01M | 305.26M | 307.26M | 305.90M | 305.55M |
| Total liabilities | 756,915,000.00 | 778,306,000.00 | 790,310,000.00 | 820,978,000.00 | 821,024,000.00 | 793,558,000.00 |
| Total equity | 938.24M | 959.83M | 963.02M | 1.00B | 1.03B | 1.05B |
| Retained earnings | 624.53M | 644.61M | 650.38M | 681.66M | 704.14M | -- |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 197.86M | 336.73M | 274.38M | 70.11M | 625.36M | 289.98M | 209.74M | 226.12M |
| Depreciation & amortization | 95.60M | 92.68M | 87.65M | 98.83M | 112.80M | 80.70M | 48.26M | 57.27M |
| Free cash flow | 113.36M | 241.22M | 192.20M | -24.49M | 539.00M | 206.45M | 159.16M | 170.21M |
| Dividends paid | -52.33M | -53.29M | -52.99M | -57.22M | -59.24M | -274.87M | -33.90M | -36.89M |
| Stock buybacks / issuance | -174.48M | -57.49M | -185.47M | -186.53M | -1.78M | -11.40M | -34.89M | -49.66M |
| Ending cash balance | 92.36M | 147.20M | 640.31M | 34.49M | 454.95M | 244.23M | 250.08M | 27.73M |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | 62.41M | 41.06M | 51.52M | 61.94M | 71.60M | 66.73M |
| Depreciation & amortization | 12.56M | 13.09M | 13.76M | 14.55M | 15.87M | 15.63M |
| Free cash flow | 49.33M | 27.87M | 39.09M | 48.14M | 55.11M | 53.98M |
| Dividends paid | -8.40M | -8.58M | -9.62M | -9.34M | -9.35M | -9.40M |
| Stock buybacks / issuance | -6.77M | -9.81M | -15.96M | -5.39M | -18.49M | -15.55M |
| Ending cash balance | 250.08M | 167.12M | 180.29M | 5.98M | 27.73M | 55.07M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 17.54 | 9.54 | 65.24 | 26.36 | 16.15 | 8.56 | 10.52 | 15.89 |
| ROA %i | 5.98 | 3.25 | 25.38 | 10.81 | 7.03 | 4.18 | 5.76 | 8.81 |
| ROIC %i | 11.27 | 6.53 | 40.41 | 18.05 | 11.51 | 6.05 | 7.90 | 12.19 |
| 5-year avg ROE %i | 18.01 | 18.00 | 27.32 | 27.90 | 26.96 | 25.17 | 25.36 | 15.50 |
| EBIT margin %i | 6.50 | 4.66 | 29.89 | 10.41 | 7.57 | 6.07 | 11.35 | 15.03 |
| FCF / sales %i | 3.02 | 7.89 | 6.06 | -- | 10.96 | 16.57 | 13.80 | 12.32 |
| Current ratioi | 1.67 | 2.53 | 2.50 | 1.92 | 2.60 | 3.78 | 3.48 | 2.37 |
| Quick ratioi | 0.87 | 1.28 | 1.63 | 0.98 | 0.90 | 2.59 | 2.43 | 1.25 |
| Debt / assetsi | 29.84 | 31.58 | 22.17 | 23.18 | 19.58 | 19.36 | 19.23 | 18.93 |
| LT debt / equityi | 71.98 | 88.36 | 52.74 | 52.98 | 41.75 | 34.98 | 34.15 | 33.28 |
| Interest coveragei | 6.42 | 4.50 | 31.24 | 17.41 | 13.91 | 47.63 | 62.63 | 33.23 |
| Revenue CAGR (3Y) %i | 10.06 | 0.50 | -3.97 | -29.65 | -22.60 | -26.76 | -4.13 | -0.88 |
| Net income CAGR (3Y) %i | 2.21 | -27.23 | 54.89 | 35.22 | 48.21 | -46.53 | -36.74 | -15.26 |
| FCF CAGR (3Y) %i | -28.97 | -3.36 | -2.17 | -- | 30.73 | 2.41 | -- | -31.90 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 10.52 | 11.50 | 11.31 | 11.53 | 15.89 | 16.30 |
| ROA %i | 5.76 | 6.32 | 6.22 | 6.38 | 8.81 | 9.14 |
| ROIC %i | 7.90 | 8.54 | 8.47 | 8.74 | 12.19 | 12.58 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.35 | 12.11 | 11.53 | 11.54 | 15.03 | 15.45 |
| FCF / sales %i | 13.80 | 12.96 | 12.82 | 12.38 | 12.32 | 13.81 |
| Current ratioi | 3.48 | 3.30 | 3.26 | 2.36 | 2.37 | 2.67 |
| Quick ratioi | 2.43 | 2.03 | 2.08 | 1.23 | 1.25 | 1.28 |
| Debt / assetsi | 19.23 | 19.92 | 19.72 | 19.61 | 18.93 | 18.88 |
| LT debt / equityi | 34.15 | 35.31 | 35.03 | 34.41 | 33.28 | 32.43 |
| Interest coveragei | 62.63 | 87.36 | 68.70 | 46.38 | 33.23 | 26.51 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Building Products is the largest reported line at 62.37% of revenue, across 2 reported segments.
- Consumer Products follows at 37.63%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Building Products62.37%
Consumer Products37.63%
Region
United States88.10%
International11.90%
Quote time 2026-10-08 08:08:16 · For reference only, not investment advice and not tailored to your situation.